It captures them, neutralizes them, and ensures they are safely eliminated from the body
Yamauchi M, Nakahara M, Hisato N, Kazuhiko S, Junnichi H & Toda G (1994) Different prevalence of hepatocellular carcinoma between patients with liver cirrhosis due to genotype II and III of hepatitis C virus
The question has shifted from "is it too expensive to cover GLP-1?" to "is it too expensive not to?" As clinical data accumulates showing that GLP-1 medications reduce the incidence and severity of the most expensive chronic diseases, payers are recognizing that proactive treatment of obesity saves money compared to treating its downstream consequences
Patients should not assume they qualify based only on an online BMI calculation
Common Cagrilintide Side Effects Research with cagrilintide has identified several predictable effects related to its mechanism of action: Gastrointestinal Effects (Most Common): Nausea (reported in 40-60% of research subjects) Vomiting (typically mild and transient) Diarrhea or constipation Abdominal discomfort Reduced appetite (intended therapeutic effect) Other Observed Effects: Injection site reactions (redness, itching) Fatigue during initial weeks Headache (usually temporary) Dizziness (particularly with rapid dose escalation) The good news is that most cagrilintide side effects diminish significantly over time as the body adapts to amylin receptor activation [7]
Diets are started, gym memberships purchased, and new routines plannedyet the weight often returns